EMMANOELA MUGHA: Open Payments
NPI 1285994079 · LINTHICUM HEIGHTS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 59 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $1,162
Food & beverage: $1,162
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $179 |
| Axsome Therapeutics, Inc. | 7 | $160 |
| ABBVIE INC. | 11 | $154 |
| Neurocrine BioSciences, Inc. | 4 | $112 |
| Vanda Pharmaceuticals Inc. | 4 | $94 |
| Corium, LLC | 6 | $93 |
| Almatica Pharma LLC | 4 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| HARMONY BIOSCIENCES LLC | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 4 | $61 |
Products named: Auvelity, VRAYLAR, REXULTI, INGREZZA, FANAPT, Azstarys, LOREEV XR, CAPLYTA.
Industry payments across MD — which companies pay providers there.
